Author

N. H. Tolia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Approach:deep learning· 1 Approach:genetic perturbation / CRISPR· 1 Organism:plant (other)· 1

Frequent Co-Authors

A. K. Kongsomboonvech· 1 shared A. R. Tobin· 1 shared B. Baro· 1 shared C. Lin· 1 shared C. Y. Kim· 1 shared D. V. Urusova· 1 shared E. S. Egan· 1 shared E.-M. M. Strauch· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. K. Kongsomboonvech

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Plasmodium falciparum exploits CD44 as a co-receptor for erythrocyte invasion

B. Baro, C. Y. Kim, C. Lin, A. K. Kongsomboonvech, M. Tetard, N. D. Salinas, N. H. Tolia, E. S. Egan

This study identifies CD44 as a co-receptor used by Plasmodium falciparum for erythrocyte invasion, showing it enhances parasite entry through cytoskeletal protein phosphorylation.

bioRxiv · Apr 12, 2023Microbiology

Conformational flexibility, lipid binding, and regulatory domains in CelTOS

H. Kumar, J. R. Jimah, F. Ntumngia, S. A. Misal, S. Jones, M. Fried, J. Adams, P. Schlesinger, N. H. Tolia

This study identifies key regions and mechanisms of CelTOS pore formation and immunogenicity, with implications for vaccine design against malaria and apicomplexan parasites.

bioRxiv · Mar 31, 2022 · PreprintMicrobiology

Inhibition of a critical malaria host-pathogen interaction by a computationally designed inhibitor targeting Plasmodium vivax DBP

A. R. Tobin, R. Crow, D. V. Urusova, J. C. Klima, N. H. Tolia, E.-M. M. Strauch

The paper designs a small, stable protein inhibitor that blocks the Plasmodium vivax DBP-DARC interaction, offering a potential therapeutic for malaria.

bioRxiv · Feb 5, 2022 · PreprintBioengineering